Intravascular Ultrasound (IVUS)

Intravascular Ultrasound (IVUS)

Global Intravascular Ultrasound (IVUS) Market to Reach US$1.1 Billion by 2030

The global market for Intravascular Ultrasound (IVUS) estimated at US$679.7 Million in the year 2023, is expected to reach US$1.1 Billion by 2030, growing at a CAGR of 7.7% over the analysis period 2023-2030. IVUS Catheters, one of the segments analyzed in the report, is expected to record a 8.4% CAGR and reach US$659.0 Million by the end of the analysis period. Growth in the IVUS Consoles segment is estimated at 6.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$247.9 Million While China is Forecast to Grow at 10.1% CAGR

The Intravascular Ultrasound (IVUS) market in the U.S. is estimated at US$247.9 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$199.1 Million by the year 2030 trailing a CAGR of 10.1% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.5% and 7.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.1% CAGR.

Global Intravascular Ultrasound (IVUS) Market - Key Trends and Drivers Summarized

Intravascular Ultrasound (IVUS) is a medical imaging methodology used primarily in cardiology to visualize the inside of blood vessels from a catheter inserted into the artery. It provides a unique perspective by offering real-time views of the vessel walls and other structures within the vessels, which is critical for diagnosing and treating vascular diseases such as atherosclerosis. IVUS is particularly useful for assessing the severity of blockages and guiding interventions like stent deployment. By emitting sound waves, an IVUS device produces detailed images of the vessel walls, allowing physicians to observe not just the lumen but also the atheromatous plaque characteristics, providing a much clearer and more accurate picture than traditional imaging techniques such as angiography.

The utilization of IVUS has been growing due to its ability to enhance the precision of percutaneous coronary interventions (PCI) and other vascular procedures. The technology is critical in the decision-making process for treatments as it assists in choosing the appropriate size of stents and ensuring their correct placement and expansion. This reduces the risks of complications such as stent thrombosis and restenosis, which are significant concerns in cardiac care. Furthermore, IVUS helps in the assessment of ambiguous angiographic images, offering a more definitive understanding of the vascular anatomy and pathology. As healthcare moves towards more personalized and precise treatment modalities, the role of IVUS in clinical settings has become increasingly vital. This shift is supported by a growing body of clinical evidence that underscores the benefits of IVUS in improving the outcomes of cardiovascular procedures.

The growth in the IVUS market is driven by several factors, including technological advancements, increased prevalence of cardiovascular diseases, and rising demand for minimally invasive procedures. Technological innovations in IVUS systems, such as improved image resolution and user-friendly interfaces, make the technology more accessible and effective for physicians. The aging global population and lifestyle-related health issues have led to a higher incidence of cardiovascular diseases, subsequently increasing the need for advanced diagnostic and treatment technologies like IVUS. Additionally, there is a growing patient preference for minimally invasive procedures, which are less painful, carry fewer risks of infection, and have quicker recovery times compared to traditional surgeries. These factors, combined with supportive government initiatives and healthcare policies promoting advanced medical equipment, are crucial in driving the adoption and expansion of IVUS technologies in medical institutions worldwide.

Select Competitors (Total 15 Featured) -

• Johnson & Johnson Services, Inc.
• Boston Scientific Corporation
• Terumo Corporation
• Teleflex, Inc.
• Siemens Healthineers AG
• Koninklijke Philips N.V.
• Pie Medical Imaging BV
• ACIST Medical Systems, Inc.
• Avinger, Inc.
• InfraReDx, Inc.
• Philips Healthcare USA
• Clarius Mobile Health Corporation

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.